Daiwa Securities Group Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01380.0%0.00%
Q2 2023$0
-100.0%
1380.0%0.00%
Q1 2023$11380.0%0.00%
Q4 2022$0
-100.0%
1380.0%0.00%
Q3 2022$1,0000.0%1380.0%0.00%
Q2 2022$1,0000.0%1380.0%0.00%
Q1 2022$1,0000.0%1380.0%0.00%
Q4 2021$1,0000.0%1380.0%0.00%
Q3 2021$1,0000.0%1380.0%0.00%
Q2 2021$1,0000.0%1380.0%0.00%
Q1 2021$1,000
-50.0%
1380.0%0.00%
Q4 2020$2,000
-66.7%
138
-66.9%
0.00%
Q3 2020$6,000
-14.3%
417
+17.8%
0.00%
Q2 2020$7,0000.0%3540.0%0.00%
Q1 2020$7,0000.0%3540.0%0.00%
Q4 2019$7,000
+75.0%
354
-7.6%
0.00%
Q3 2019$4,000
+100.0%
3830.0%0.00%
Q2 2019$2,0000.0%383
+46.7%
0.00%
Q1 2019$2,0000.0%2610.0%0.00%
Q4 2018$2,000
-50.0%
2610.0%0.00%
Q3 2018$4,0000.0%2610.0%0.00%
Q2 2018$4,0000.0%2610.0%0.00%
Q1 2018$4,0002610.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders